Anavex Life Sciences Corp (AVXL)

[falconer66a]

What can I explain to my wife?

It appears that Blackrock owns 7.2% of AVXL common stock.

Interesting. Blackrock, claimed to be “the world's largest asset manager,” has the same disregard of the Anavex experts who post their warnings on this board as do I. For me, my holding of a rather moderate AVXL position for many years can be explained by the fact that I’m not a stock asset manager of any experience or competence. As a lone retail holder of some AVXLs I’m simply deceived regarding Anavex’s potential future. What could I know about either the Anavex science (well, quite a bit, with my formal training in biology), or far worse, how badly the company is managed and how deficient its clinical trials are?

My percent holding of all of the AVXL shares is less than one one-hundredth of one percent. But Blackrock has the number 7 in front of their ownership percent decimal. They own about 5,612,216 AVXL shares.

Can you believe it, at the share price of $10.52, the company has $59,040,512 of client dollars tied up in Anavex Life Sciences Corp right now.

Don’t they know? The real biotech investment experts are here, so graciously sharing their informed perspectives on Anavex. The company is going nowhere. The Alzheimer’s trial was a bust. No one has seen anything happening with the Rett syndrome data. There is supposed to be something coming from a clinical trial for Parkinson’s disease dementia. The experts here tell us each day that Anavex is all bogus; can’t go anywhere. Bad corporate leadership. Fudged or incomplete data presentations.

So, when Anavex goes bust, I’ll have to explain to my wife that I only invested some discretionary dollars from our budget, and the several thousands of dollars I will have lost won’t compromise our economic future in any way.

But what’s Blackrock management going to say? They will have to plead ignorance, for not being aware of the concentration of biotech investment advice on this particular message board. Nothing can match it.